109 related articles for article (PubMed ID: 18852029)
1. Analysis of APBB2 gene polymorphisms in sporadic Alzheimer's disease.
Golanska E; Sieruta M; Gresner SM; Hulas-Bigoszewska K; Corder EH; Styczynska M; Peplonska B; Barcikowska M; Liberski PP
Neurosci Lett; 2008 Dec; 447(2-3):164-6. PubMed ID: 18852029
[TBL] [Abstract][Full Text] [Related]
2. APBB2 genetic polymorphisms are associated with severe cognitive impairment in centenarians.
Golanska E; Sieruta M; Gresner SM; Pfeffer A; Chodakowska-Zebrowska M; Sobow TM; Klich I; Mossakowska M; Szybinska A; Barcikowska M; Liberski PP
Exp Gerontol; 2013 Apr; 48(4):391-4. PubMed ID: 23384821
[TBL] [Abstract][Full Text] [Related]
3. Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkers.
Lamsa R; Helisalmi S; Herukka SK; Tapiola T; Pirttila T; Vepsalainen S; Hiltunen M; Soininen H
Dement Geriatr Cogn Disord; 2007; 24(2):146-50. PubMed ID: 17622762
[TBL] [Abstract][Full Text] [Related]
4. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
[TBL] [Abstract][Full Text] [Related]
5. TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels.
Laws SM; Perneczky R; Wagenpfeil S; Müller U; Förstl H; Martins RN; Kurz A; Riemenschneider M
Hum Mutat; 2005 Jul; 26(1):29-35. PubMed ID: 15895461
[TBL] [Abstract][Full Text] [Related]
6. Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease.
Dhaenens CM; Van Brussel E; Schraen-Maschke S; Pasquier F; Delacourte A; Sablonnière B
Neurosci Lett; 2004 Sep; 368(3):290-2. PubMed ID: 15364413
[TBL] [Abstract][Full Text] [Related]
7. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
[TBL] [Abstract][Full Text] [Related]
8. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.
Poli M; Gatta LB; Lovati C; Mariani C; Galimberti D; Scarpini E; Biunno I; Musicco M; Dominici R; Albertini A; Finazzi D
Neurobiol Aging; 2008 Oct; 29(10):1494-501. PubMed ID: 17466415
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of multiple presenilin 2 SNPs for association with early-onset sporadic Alzheimer disease.
Howell WM; Brookes AJ
Am J Med Genet; 2002 Aug; 111(2):157-63. PubMed ID: 12210343
[TBL] [Abstract][Full Text] [Related]
10. Association analysis of methionine synthase gene 2756 A>G polymorphism and Alzheimer disease in a Chinese population.
Zhao HL; Li XQ; Zhang ZX; Bi XH; Wang B; Zhang JW
Brain Res; 2008 Apr; 1204():118-22. PubMed ID: 18329006
[TBL] [Abstract][Full Text] [Related]
11. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.
Riemenschneider M; Konta L; Friedrich P; Schwarz S; Taddei K; Neff F; Padovani A; Kölsch H; Laws SM; Klopp N; Bickeböller H; Wagenpfeil S; Mueller JC; Rosenberger A; Diehl-Schmid J; Archetti S; Lautenschlager N; Borroni B; Müller U; Illig T; Heun R; Egensperger R; Schlegel J; Förstl H; Martins RN; Kurz A
Hum Mol Genet; 2006 Aug; 15(16):2446-56. PubMed ID: 16825285
[TBL] [Abstract][Full Text] [Related]
12. Association study of the chemokine, CXC motif, ligand 1 (CXCL1) gene with sporadic Alzheimer's disease in a Japanese population.
Tamura Y; Sakasegawa Y; Omi K; Kishida H; Asada T; Kimura H; Tokunaga K; Hachiya NS; Kaneko K; Hohjoh H
Neurosci Lett; 2005 May; 379(3):149-51. PubMed ID: 15843053
[TBL] [Abstract][Full Text] [Related]
13. Association study of the GAB2 gene with the risk of developing Alzheimer's disease.
Chapuis J; Hannequin D; Pasquier F; Bentham P; Brice A; Leber I; Frebourg T; Deleuze JF; Cousin E; Thaker U; Amouyel P; Mann D; Lendon C; Campion D; Lambert JC
Neurobiol Dis; 2008 Apr; 30(1):103-6. PubMed ID: 18272374
[TBL] [Abstract][Full Text] [Related]
14. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.
Helisalmi S; Tarvainen T; Vepsäläinen S; Koivisto AM; Hiltunen M; Soininen H
Neurosci Lett; 2008 Aug; 441(2):233-6. PubMed ID: 18573313
[TBL] [Abstract][Full Text] [Related]
15. A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.
Blain JF; Aumont N; Théroux L; Dea D; Poirier J
Eur J Neurosci; 2006 Sep; 24(5):1245-51. PubMed ID: 16965549
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between the polymorphisms of beta-site APP-cleaving enzyme 2 (BACE2) 5'-flanking region and sporadic Alzheimer's disease.
Yu Y; Jia J
Brain Res; 2009 Feb; 1257():10-5. PubMed ID: 19124009
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
18. Implication of sex and SORL1 variants in italian patients with Alzheimer disease.
Cellini E; Tedde A; Bagnoli S; Pradella S; Piacentini S; Sorbi S; Nacmias B
Arch Neurol; 2009 Oct; 66(10):1260-6. PubMed ID: 19822782
[TBL] [Abstract][Full Text] [Related]
19. Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease.
Mariani E; Seripa D; Ingegni T; Nocentini G; Mangialasche F; Ercolani S; Cherubini A; Metastasio A; Pilotto A; Senin U; Mecocci P
J Neurol Sci; 2006 Sep; 247(2):187-91. PubMed ID: 16784755
[TBL] [Abstract][Full Text] [Related]
20. Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Bifaro L; Menga R; Santamato A; Seripa D; Pilotto A; Capurso A; Panza F
Neurosci Lett; 2008 Feb; 432(3):237-42. PubMed ID: 18248894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
